Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Work In Process (2022 - 2026)

HeartSciences (HSCS) has disclosed Work In Process for 4 consecutive years, with $21741.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Work In Process changed 0.0% year-over-year to $21741.0, compared with a TTM value of $21741.0 through Oct 2025, changed 0.0%, and an annual FY2025 reading of $21741.0, changed 0.0% over the prior year.
  • Work In Process was $21741.0 for Q4 2025 at HeartSciences, roughly flat from $21741.0 in the prior quarter.
  • Across five years, Work In Process topped out at $21741.0 in Q2 2022 and bottomed at $21741.0 in Q2 2022.
  • Average Work In Process over 4 years is $21741.0, with a median of $21741.0 recorded in 2022.
  • Peak annual rise in Work In Process hit 0.0% in 2023, while the deepest fall reached 0.0% in 2023.
  • Year by year, Work In Process stood at $21741.0 in 2022, then changed by 0.0% to $21741.0 in 2023, then changed by 0.0% to $21741.0 in 2024, then changed by 0.0% to $21741.0 in 2025.
  • Business Quant data shows Work In Process for HSCS at $21741.0 in Q4 2025, $21741.0 in Q3 2025, and $21741.0 in Q2 2025.